1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Pneumococcal Immunisation: new trials by email Literature Review of Pneumococcal Immunisation trials Research Report on Pneumococcal Immunisation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus), DTwP-HepB-Hib pentavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b), Inactivated Poliomyelitis Vaccine - Pertussis Immunisation, Diphtheria Immunisation | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 460 | 2020-06-28 | 2025-09-22 |
13-valent pneumococcal vaccine (1) · Diphtheria Toxoid (1) · Hepatitis B Surface Antigens (1) · Poliovirus Vaccine, Inactivated (1) · RIX4414 vaccine (1) · Tetanus Toxoid (1)
Sanofi Pasteur, a Sanofi Company (1)
Thailand (1)